Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo
Clicks: 371
ID: 111417
1997
Children in the ribavirin treatment group did not have exacerbated respiratory symptoms compared with those in the control group, and their pulmonary function measurements were equal to those of the placebo-treated group, suggesting no long term adverse effect or benefit of ribavirin therapy.
| Reference Key |
ce1997thelong
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Long CE;Voter KZ;Barker WH;Hall CB;; |
| Journal | the pediatric infectious disease journal |
| Year | 1997 |
| DOI | DOI not found |
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
female
male
Child
Recurrence
preschool
Clinical Trial
Randomized Controlled Trial
follow-up studies
hospitalization
c b hall
antiviral agents / therapeutic use*
ribavirin / therapeutic use*
pmid:9384333
doi:10.1097/00006454-199711000-00004
c e long
k z voter
growth
respiratory syncytial virus infections / drug therapy*
respiratory tract infections / drug therapy*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.